Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corvus Pharmaceuticals

3.59
-0.0300-0.83%
Pre-market: 3.670.0800+2.23%08:09 EDT
Volume:480.23K
Turnover:1.73M
Market Cap:244.61M
PE:-3.51
High:3.67
Open:3.57
Low:3.51
Close:3.62
Loading ...
Sep 10, 2020

Major Issues Report

8-K - Current report
Jul 30, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2020

Major Issues Report

8-K - Current report
Jul 09, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 07, 2020

Major Issues Report

8-K - Current report
Jun 10, 2020

Major Issues Report

8-K - Current report
May 29, 2020

Major Issues Report

8-K - Current report
Apr 30, 2020

Major Issues Report

8-K - Current report
Apr 30, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Apr 30, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 17, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 20, 2020

Major Issues Report

Current report, item 5.02
Mar 17, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 09, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 18, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals